Advancing Cancer Research: Genomic Profiling with QIAseq xHYB Trinity CGP
- Enabling comprehensive cancer biomarker detection using QIAseq xHYB enrichment and Trinity CGP analysis technologies.
- Identifying novel biomarkers and pathway-level alterations in breast and ovarian cancers.
- Supporting feasibility studies to integrate comprehensive genomic profiling into translational and precision oncology research
Sponsored by QIAGEN